Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purified non-haemogenic human umbilical vein endothelial cells or adult dermal microvascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.
Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purified non-haemogenic human umbilical vein endothelial cells or adult dermal microvascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.
Manufacture of autologous, engraftable haematopoietic stem and progenitor cells (HSPCs) offers tremendous therapeutic potential. Using in vitro cultures, human pluripotent stem cells can be differentiated into haematopoietic progenitors, which often have limited expansion potential and do not engraft myeloablated recipients [1] [2] [3] . Enforced expression of transcription factors has also been used to reprogram somatic cells into haematopoietic lineages [4] [5] [6] . Employing cellular fusion, we have shown that direct conversion of somatic cells into fetal HSPCs is also feasible 7 . However, these previous efforts have been unable to produce human haematopoietic cells capable of long-term multilineage engraftment [4] [5] [6] [7] . We hypothesized that in addition to transcription factor expression, haematopoietic specification and long-term engraftment may require inductive signals from the microenvironment. Indeed, the central instructive role of tissue-specific endothelial cells 8 in supporting organ regeneration 9,10 , including haematopoietic stem-cell (HSC) self-renewal and reconstitution of multilineage haematopoiesis, has recently come to light [11] [12] [13] [14] [15] [16] [17] [18] .
In mammals, definitive HSCs originate in the vascular microenvironment of the aorta-gonad-mesonephros (AGM) [19] [20] [21] [22] [23] [24] , placenta 25 and arterial vessels 26 . Putative HSCs bud off from haemogenic vascular cells lining the dorsal aorta floor and umbilical arteries, where they are in cellular contact with non-haemogenic endothelial cells 27 . This ontological endothelial-to-haematopoietic transition (EHT) is mediated in part through expression of the transcription factor RUNX1 (ref. 21), its non-DNAbinding partner core binding factor-b (ref. 28), GFI1 and GFI1b (refs 29, 30) . However, the contribution of microenvironmental inductive signals provided by anatomically distinct niches and tissue-specific vascular niches 8 within the AGM, fetal liver and placenta remain poorly defined.
We have identified a minimal set of four transcription factors-FOSB, GFI1, RUNX1 and SPI1 (FGRS)-that reprogram full-term human umbilical vein endothelial cells (HUVECs) and human adult dermal microvascular endothelial cells (hDMECs) into haematopoietic cells with long-term MPP activity (rEC-hMPP). The reprograming was successful only when a unique serum-free vascular niche platform was used. Subsets of rEC-hMPPs were immunophenotypically marked as HSCs and were capable of long-term primary and secondary multilineage engraftment in immunodeficient mice. We demonstrate that constitutive or transient expression of FGRS transcription factors combined with inductive signals from specialized vascular niche cells 1, 11, 31 are essential for efficient conversion of endothelial cells into rEC-hMPPs.
FGRS and vascular induction reprogramming
Primitive HSCs emerge on a vascular bed during development. Thus, we hypothesized that executive functions of the vascular niche could have an important role during reprogramming by inducing and maintaining nascent haematopoietic cells. Since serum impairs vascular function and interferes with expansion of HSCs and MPPs, we devised a vascular niche model in which endothelial cells transduced with the adenoviral E4ORF1 gene (E4ECs, VeraVecs) could be cultured without serum 1, 11, 12, 31 . E4ORF1 activates survival pathways in endothelial cells without provoking proliferation or cellular transformation and thereby maintains tissue-specific functional and metabolic attributes of endothelial cells. E4ECs derived from HUVECs 1, 11, 12, 31 or endothelial cells purified and propagated from haematopoietic organs 32,33 balance self-renewal and differentiation of human and mouse long-term HSCs and MPPs by producing physiological levels of Notch ligands, Kit ligand, BMPs, Wnts and other angiocrine factors 14 .
To identify transcription factors that drive EHT, we first identified transcription factors differentially expressed by Lin 2 CD34 1 umbilical cord HSPCs, but not by HUVECs (Extended Data Fig. 1a-d ). We then cultivated CD45 2 CD133 2 c-Kit 2 CD31 1 HUVECs that were devoid of haemogenic potential 34 ( Fig. 1a ) and transduced them with lentiviral vectors expressing various combinations of differentially expressed transcription factor transcripts using GFP as a marker. After 3 days, transduced HUVECs were re-plated onto subconfluent serum-free E4EC monolayers, to force cellular interaction of HUVECs potentially undergoing EHT with inductive vascular niche cells. Within 2 weeks of co-culture with E4ECs, round GFP 1 CD45 1 cells began to bud from transduced HUVECs and form grape-like colonies (Fig. 1b ). Systematic one-by-one dropout of candidate transcription factors demonstrated that expression of FGRS transcription factors was necessary and sufficient for haematopoietic reprogramming of HUVECs (Extended Data Fig. 1b , c).
Co-culture of FGRS-transduced endothelial cells with E4EC monolayers augmented the yield and stability of the haematopoietic-like colonies, which displayed morphological features of haematopoietic progenitors ( Fig. 1c ). Within 4 weeks of co-culture with E4ECs, FGRS-transduced endothelial cells began to proliferate and form GFP 1 CD45 1 colonies (Fig. 1a , c). Serum suppressed colony formation and naive HUVECs could not survive without serum and failed to support the emergence of CD45 1 cells (Fig. 1d ). FGRS transduction of 5 3 10 4 HUVECs followed by 3 weeks of serum-free co-culture with E4ECs yielded 32.3 6 10.5 colonies ( Fig. 1d ) (efficiency of reprogramming is 1.5%; see Methods), occasionally forming multi-colony structures (Extended Data Fig. 2a ). Once colonies formed, proliferation of GFP 1 cells increased and after 5 weeks of co-culture with E4ECs, up to 20 3 10 6 GFP 1 CD45 1 cells were produced, a ,400fold expansion of the input FGRS-transduced endothelial cells ( Fig. 1d ). Since clonal CD45 1 cells, but not CD45 2 cells, form colonies it is unlikely that E4ECs are mistakenly identified as haematopoietic cells (Extended Data Fig. 2b, c) . Thus, FGRS-transduced endothelial cells required sustained inductive and supportive signals from the E4EC vascular niche for efficient haematopoietic reprogramming.
Current efforts to differentiate pluripotent stem cells into repopulating haematopoietic cells have had limited success [1] [2] [3] . We hypothesized 
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that FGRS transcription factors could augment haematopoietic differentiation of human embryonic stem (ES) cells. To test this, we first differentiated human ES cells into endothelial cells (hES-EC) 35,36 and then transduced purified VEGFR2 1 CD144 1 hES-ECs with FGRS. Although this approach generated CD45 1 CD144 2 progeny (Extended Data Fig. 2d ), these cells did not form stable haematopoietic-like colonies and did not proliferate ( Fig. 1a , black line). Thus, hES-ECs are not as permissive as HUVECs for reprogramming into haematopoietic cells.
rEC-hMPPs have features of multilineage progenitors
During reprogramming, GFP 1 FGRS-transduced endothelial cells and vascular-induced haematopoietic-like colonies lost CD31 expression but gained the expression of human haematopoietic markers hCD45, hCD43, hCD90 (also called Thy-1) and hCD14 ( Fig. 2a and Extended Data Fig. 2e ). In contrast, the GFP 2 E4ECs remained CD31 1 CD34 1 CD45 2 . Importantly, a subset of GFP 1 hCD45 1 FGRS-transduced endothelial cell progeny manifested the immunophenotype of human HSCs (hCD45 1 Lin 2 hCD45RA 2 hCD38 2 hCD90 1 hCD34 1 ) and MPPs (hCD45 1 Lin 2 hCD45RA 2 hCD38 2 hCD90 2 hCD34 1 ) 37,38 ( Fig. 2b) . To assess the function of various populations of these endothelial cells reprogrammed into human MPPs (rEC-hMPPs), we sorted 4-week-old GFP 1 hCD45 1 hCD34 1 rEC-hMPPs and seeded them in colony-forming cell (CFC) assays to enumerate progenitor cells. The rEC-hMPPs gave rise to GFP 1 colonies with CFC-GEMM (granulocytic/erythroid/megakaryocytic/ monocytic), CFC-GM (granulocytic/macrophage) and haemoglobinized burst-forming unit-erythroid BFU-E morphologies ( Fig. 2c ). Flow cytometry and cytospin analysis documented the presence of cells with morphological ( Fig. 2d ) and immunophenotypic features of granulocyte/ macrophage (CD11b 1 , CD14 1 ), erythroid (CD235 1 ), dendritic (CD83 1 ) and megakaryocyte (CD41a 1 ) progenies (Extended Data Fig. 2f ). The function of rEC-hMPP-derived macrophages was corroborated using a phagocytosis assay (Extended Data Fig. 2g ). Thus, rEC-hMPPs contain functional multilineage progenitor cells.
rEC-hMPPs engraft long-term into primary recipients
To assess the engraftment potential of rEC-hMPPs, we transplanted 1.5 3 10 6 GFP 1 hCD45 1 rEC-hMPPs into adult sublethally irradiated (275 rad) immunocompromised NSG mice ( Fig. 3a ). We detected circulating human CD45 1 cells in the peripheral blood of recipient engrafted mice from 2 to 44 weeks ( Fig. 3b ) and found hCD45 2 hCD235 1 erythroid cells 16 weeks post-transplantation ( Fig. 3c ). We then sorted human CD45 1 (hCD45 1 ) cells from bone marrow of recipient mice 22-24 weeks after transplantation and cultured them for 24 h. The hCD45 1 hCD34 1 cells were resorted and seeded into CFC assays. They formed CFC-GM, 
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CFC-GEMM and BFU-E haematopoietic colonies with typical myeloid progeny morphologies ( Fig. 3d ). Hence, rEC-hMPPs are capable of robust multilineage engraftment.
rEC-hMPPs arise from non-haemogenic endothelium
To rule out the possibility that rEC-hMPPs are derived from rare contaminating haemogenic cells 25,34 , we tested whether naive endothelial cells or highly purified, mature CD45 2 CD144 1 CD31 1 CD62E (E-selectin) 1 endothelial cells 32,33 could form haematopoietic cells when cultured in optimal pro-haematopoietic media. Neither serum withdrawal nor addition of haematopoietic cytokines induced formation of CD45 1 CD34 1 cells from naive HUVECs (Extended Data Fig. 3a, b ). However, FGRS transduction and E4EC induction of the clonal or oligo-clonal CD45 2 CD144 1 CD31 1 CD62E 1 mature endothelial cells 32,33 generated functional rEC-MPPs with high efficiency (Extended Data Figs 3c-e and 4a-c). Thus, rEC-hMPPs are not derived from a scarce population of spontaneously differentiating endothelial cells with pre-existing haemogenic potential.
The bone marrow of robustly engrafted recipient NSG mice contained a small population of hCD45 1 cells with Lin 2 CD45RA 2 CD38 2 CD90 2 CD34 1 immunophenotype of human MPPs 37 (Fig. 3e ). To ensure that engrafted cells were derived from FGRS-transduced endothelial cells, we purified hCD45 1 cells from recipient bone marrow ( Fig. 3f ) and seeded single cells into 96-well plates for whole-genome amplification (WGA) and detection of viral vector integration. All hCD45 1 cells had been transduced by lentiviral vectors, and 19 of 21 cells showed integration of all four FGRS transcription factors ( Fig. 3f and Extended Data Fig. 5 ). To verify that these cells were the progeny of rEC-hMPPs, we seeded hCD45 1 cells for CFC assays to examine viral integration in individual colonies ( Fig. 3g) . We demonstrated that all tested colonies were derived from cells that had integrated the lentiviral vectors expressing FGRS (Fig. 3g ). Therefore, engrafted human haematopoietic cells were derived from transplanted rEC-hMPPs.
To test whether FGRS-induced reprogramming triggered expression of endogenous human FGRS genes 24 , we expressed genetically distinct murine transcription factors (mFGRS) using inducible lentiviral vectors to reprogram HUVECs into rEC-hMPPs and then assessed expression of the endogenous human FGRS genes. Transient expression of mFGRS with E4EC co-culture for 3 weeks induced a 100-fold greater expression of endogenous genes than that of switched-off mFGRS transcripts (Extended Data Fig. 6a -c). Therefore, rEC-hMPPs do not require continuous expression of exogenous FGRS transcription factors to sustain their haematopoietic cell fates.
Furthermore, we speculated that enforced SPI1 expression might prevent rEC-hMPPs from differentiating into T cells 39, 40 . Therefore, we constitutively expressed FGR transcription factors with a Tet-inducible SPI1 and E4EC induction and identified a small but significant population of CD3 1 T cells (Extended Data Fig. 6d , e). Thus, generation of lymphoid cells from rEC-hMPPs could be optimized by transient expression of specific transcription factors.
Reprogramming adult endothelial cells to rEC-hMPPs
To test whether our approach could reprogram adult human endothelial cells, we transduced human DMECs (hDMECs) with FGRS transcription factors and propagated them on serum-free E4EC monolayers ( Fig. 4a ). After 4 weeks, GFP 1 hCD45 1 hCD34 1 cells were sorted for CFC assay. The rEC-hMPPs yielded cells with morphological features of haematopoietic cells (Fig. 4b , left panel) and functional myeloid CFC-GM, CFC-GEMM and BFU-Es ( Fig. 4b , middle panel), containing CD235 1 erythroid, hCD33 1 hCD14 1 hCD11b 1 macrophage/monocyte, and hCD83 1 dendritic cell progenies ( Fig. 4b , middle panel, and Extended Data Fig. 7a ).
Next, we compared the transcriptional profiles of rEC-hMPPs before and after NSG engraftment to those of naive HUVECs, hDMECs and purified Lin 2 CD34 1 cord blood HSPCs (Fig. 4c ). FGRS transduction plus E4EC induction activated haematopoietic genes and downregulated vascular gene signatures ( Fig. 4c ). Importantly, 22 weeks posttransplantation, CD45 1 CD34 1 rEC-hMPPs had a transcription pattern similar to normal hCD34 1 cord blood HSPCs and distinct from the endothelial cells from which they were derived ( Fig. 4c) . Notably, pluripotency genes were not induced in rEC-hMPPs, indicating that reprogramming does not require transition through a destabilizing pluripotent intermediate ( Fig. 4d ). 9 and 10a). c, Analysis of the total mononuclear peripheral blood cells at 16 weeks after transplantation of hCD45 1 and mouse CD45 1 (mCD45 1 ) cells revealed the presence of hCD45 1 (15.9%) and human non-erythroid circulating cells (left panel). We gated on the FSC/SSC hCD45 2 erythroid compartment (red gate) and typical human non-erythroid hCD45 1 compartment (blue gate) (middle and right panels). d, rEC-hMPPs isolated from the host retained their multilineage potential in vitro; secondary CFC assay. Engraftment of mouse bone marrow 22 weeks after transplantation is shown (left panel). The cells were expanded in vitro for 24 h (second panel from left) and FACS resorted for hCD45 1 hCD34 1 cells for CFC assay. Wright-Giemsa stain (third panel from left) of the cytospin of the cells from CFC assay is shown (original magnification, 3100). The far-right panel shows quantification of the CFCs. Error bars are average 6 s.d. e, Phenotypic analysis of in vivo 22-weeks engrafted rEC-hMPPs in bone marrow shows human CD45 1 Lin 2 CD45RA 2 CD38 2 CD90 2 CD34 1 MPPs. f, Identification of viral integration on a single-cell level. Whole-genome amplification (WGA) of 21 hCD45 1 cells isolated from a host mouse (e). Quantification of the analysis is shown in the right graph. g, Identification of viral integration on a single-colony level. Lin 2 CD45RA 2 CD38 2 CD90 2 CD34 1 cells (10 cells) were used for a CFC assay. We detected all four FGRS viral vectors in all CFC colonies tested (bottom image; letters F (FOSB), G (GFI1), R (RUNX1) and S (SPI1) show PCR products specific for each of these factors in the right-hand colony; scale bar, 1,000 mm).
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rEC-hMPPs engraft primary and secondary recipients
To assess the engraftment potential of hDMEC-derived rEC-hMPPs, we transplanted 1 3 10 5 CD45 1 GFP 1 rEC-hMPPs into sublethally irradiated (100 rad) 2-week-old neonatal NSG mice ( Fig. 5a ). Circulating hCD45 1 cells were detected in the peripheral blood of recipient animals 4 weeks (2.09 6 1.27%), 6 weeks (4.46 6 3.66%) and 12 weeks (4.05 6 3.50%) after transplantation ( Fig. 5a ). Fourteen weeks post-transplantation, human haematopoietic cells were found in peripheral blood, bone marrow and spleen ( Fig. 5a and Extended Data Fig. 7b-d) . Notably, these recipient animals harboured myeloid and lymphoid populations, including hCD19 1 B cells (10.13 6 4.98%), hCD56 1 natural killer cells (1.62 6 0.67%), hCD11b 1 monocyte/macrophages (27.666 8.92%) and hCD41a 1 megakaryocytes (4.90 6 1.51%) in their spleens ( Fig. 5a and Extended Data Fig. 7b-d ). Hence, rEC-hMPPs are capable of prolonged multilineage haematopoietic engraftment.
The bone marrow of primary recipient mice (weeks 12-14) contained populations with the immunophenotype of human HSCs (hCD45 1 Lin 2 hCD45RA 2 hCD38 2 hCD90 1 hCD34 1 , 10.37 6 2.55%) and MPPs (hCD45 1 Lin 2 hCD45RA 2 hCD38 2 hCD90 2 hCD34 1 , 13.83 6 2.14%) (Extended Data Fig. 7d ) 37,38 . Because these populations can self-renew, we tested whether bone marrow cells of mice engrafted by primary rEC-hMPPs ( 
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and 23 weeks (26.3 6 25.7%) post-transplantation ( Fig. 5b) . Thus, subpopulations of rEC-hMPPs can self-renew and are capable of durable myeloid and lymphoid engraftment in NSG mice-characteristics similar to true hMPPs. To examine whether individual rEC-hMPPs retained clonal multilineage potential, we isolated hCD45 1 hCD34 1 cells from the bone marrow of a secondary robustly engrafted mouse 15 weeks post-transplantation and then assessed the multilineage CFC activity in clonal (1 cell per well), oligo-clonal (2 and 5 cells per well) and bulk (1,000 cells per well) sorted cells (Fig. 5c, d) . All single-cell-derived colonies displayed multilineage differentiation, including hCD33 1 hCD14 1 hCD11b 1 myeloid, hCD41 1 megakaryocytic and CD235 1 erythroid progenies (Fig. 5c, d) , indicating that engrafted rEC-hMPPs from secondary transplants retained their MPP potential. Thus, individual cells within the rEC-hMPPs have the immunophenotypic and functional attributes of HSPC-like/selfrenewing hMPPs (Fig. 5e) .
Notably, rEC-hMPPs isolated from primary and secondary engrafted mice showed no evidence of malignant transformation (Extended Data  Figs 8, 9 , 10a) or genetic abnormalities (Extended Data Fig. 10b ).
Discussion
The availability of engraftable autologous human cells offers the potential to cure a wide spectrum of benign and malignant haematological disorders. Previous efforts using pluripotent stem cells have been handicapped by low efficiency and poor engraftment 2,3,41,42 . Here, we have taken advantage of an ontological link between endothelial and haematopoietic cells to efficiently reprogram mature, fetal and adult endothelial cells into engraftable self-renewing hMPPs without transitioning through a potentially destabilizing pluripotent intermediate. Just as support from non-haemogenic vascular cells is important for EHT during development, we found that the instructive contribution of the vascular niche was central to reprogramming endothelial cells to haematopoietic cells.
Differentiating pluripotent stem cells or expanding AGM-derived cells to engraftable haematopoietic cells has been inefficient when stromal cells have been used for niche-like support 2, 3, 41 . This could be due to: (1) poor inductive function of stromal cells in serum-free culture; and/ or (2) distinguishing features of endothelial cells that resemble the haematogenic niche cells that support EHT [11] [12] [13] [14] [15] . For example, E4ECs produce the proper physiological levels of inductive angiocrine factors, including Notch, BMP and c-Kit pathways 14 that are important for EHT 43 . Thus, adult organ-specific pro-haematopoietic vascular niches, such as HUVECs [11] [12] [13] [14] [15] [16] [17] [18] , bone marrow [11] [12] [13] [14] [15] [16] [17] [18] 32, 33 , hepatic and splenic sinusoids 8 may share functional characteristics with EHT-inductive niche cells.
The rEC-hMPPs can engraft primary and secondary recipient mice with individual cells capable of differentiating to multiple haematopoietic lineages. However, the recipient microenvironmental signals and temporal aspects of reprogramming influence the outcome of xenograft studies. NSG mice lack the proper niches for T-cell differentiation and we were not able to determine whether engrafted rEC-hMPPs could give rise to T cells in vivo. We found that temporally restricted expression of SPI1, along with sustained FGR, increased lymphoid differentiation of the rEC-hMPPs, suggesting that sustained SPI1 interfered with lymphogenesis. Notably, even transient expression of FGRS is sufficient to activate endogenous transcription factors. The age of recipient mice was also important because transplantation of neonatal (2-week-old) NSG mice enhanced lymphoid engraftment by rEC-MPPs. Therefore, temporal and chronological expression of FGRS transcription factors with proper stoichiometry combined with vascular niche signals appears to increase the yield of rEC-hMPPs with authentic multilineage, longterm, self-renewing HSPC function.
Direct reprogramming of endothelial cells into engraftable HSPCs coordinated by the inductive signals conveyed by tissue-specific vascular niches offers an innovative way to decipher the hierarchy of transcription factors and microenvironmental cues that guide haematopoietic development. Our approach lays a foundation for engineering engraftable autologous rEC-hMPPs and potentially true HSCs for treatment of patients with haematological disorders.
METHODS SUMMARY
Endothelial cells were reprogrammed into haematopoietic cells by transduction with transcription factors and vascular niche induction. To establish vascular niche platform, endothelial cells were purified and transduced with a lentiviral vector expressing the adenoviral E4ORF1 gene (E4ECs, VeraVecs, Angiocrine Bioscience, New York, NY). Purified CD45 2 CD133 2 c-Kit 2 CD31 1 and clonal populations of CD45 2 CD 144 1 CD31 1 CD62E 1 full-term human umbilical vein endothelial cells (HUVECs) and adult primary human dermal microvascular endothelial cells (hDMEC) were cultured in endothelial cell growth medium. Then, HUVECs or hDMECs were transduced with lentiviral vectors expressing GFP and a combination of transcription factors: FOSB, GFI1, RUNX1 and SPI1 (FGRS). After 3 days, GFP 1 FGRS-transduced endothelial cells were plated in co-culture with 30-50% subconfluent E4EC monolayers supplemented with serum-free haematopoietic media composed of Stem-Span SFEM, 10% KnockOut serum replacement, 5 ng ml 21 FGF-2, 10 ng ml 21 EGF, 20 ng ml 21 SCF, 20 ng ml 21 FLT3, 20 ng ml 21 TPO, 20 ng ml 21 IGF-1, 10 ng ml 21 IGF-2, 10 ng ml 21 IL-3 and 10 ng ml 21 IL-6. After 3-4 weeks of co-culture, outgrown GFP 1 reprogrammed endothelial cells into human multipotent progenitor cells (rEC-hMPPs) formed typical grape-like haematopoietic colonies. After 4 weeks, human CD45 1 rEC-hMPPs were FACS sorted for: (1) immunophenotypic analyses;
(2) methylcellulose-CFC assay; (3) molecular profiling; (4) comparative genomic hybridization; and (5) transplanted retro-orbitally into primary sublethally irradiated (275 rad) 6-week-old NSG mice or sublethally irradiated (100 rad) 2-weekold mice neonates. After 3 months, sorted, bone-marrow-derived human CD45 1 cells (hCD45 1 cells) or whole bone marrow of the primary engrafted mice were transplanted into secondary recipients. After 3 months of primary and 6 months of the secondary transplantation, engrafted hCD45 1 cells in bone marrow, spleen and peripheral blood of mice were FACS sorted and processed for: (1) multivariate immunophenotypic analyses; (2) clonal and oligo-clonal CFC assay; and (3) molecular profiling. Tissues of the engrafted mice were processed for histological examination to rule out malignant transformation.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
METHODS
Fetal and adult endothelial cells used for reprogramming. Full-term human umbilical vein endothelial cells (HUVECs) were obtained as previously described 32, 33 . Multiple purified populations of CD45 2 CD133 2 c-Kit 2 CD31 1 HUVECs were isolated from separate umbilical cords (n 5 8) and were cultured in endothelial growth media (EM): Medium 199 (Thermo Scientific: FB-01), 20% fetal bovine serum (Omega Scientific), 20 mg ml 21 endothelial cell supplement (Biomedical Technologies: BT-203), 13 Pen/Strep, and 20 units ml 21 heparin (Sigma: H3149-100KU). Multiple batches (n 5 3) of adult primary human dermal microvascular endothelial cells (hDMECs) were purchased from ScienCell Research Laboratories (catalogue 2020). In addition, cultured HUVECs were passaged for 3-5 times and then CD45 2 CD144 1 CD 31 1 CD62E 1 HUVECs were sorted for clonal analyses to rule out contamination with pre-existing haemogenic endothelial cells.
For reprogramming experiments, transduced HUVECs or hDMECs were cocultured with E4ECs in serum-free haematopoietic media (HM) formulated as StemSpan SFEM (StemCell Technologies), 10% KnockOut Serum Replacement (Invitrogen), 5 ng ml 21 bFGF (FGF-2), 10 ng ml 21 EGF, 20 ng ml 21 SCF (soluble Kit-ligand), 20 ng ml 21 FLT3, 20 ng ml 21 TPO, 20 ng ml 21 IGF-1, 10 ng ml 21 IGF-2, 10 ng ml 21 IL-3, 10 ng ml 21 IL-6 (all from Invitrogen, eBioscience, or Peprotech). Manufacture of vascular niche platform. To establish the vascular niche monolayers, HUVECs were purified and transduced with lentiviral vector carrying a cassette of adenoviral E4ORF1 gene (E4ECs) as previously described 31 or obtained as VeraVecs from Angiocrine Bioscience, New York, NY. E4ECs proliferate in serumfree and xenobiotic-free conditions only supplemented with minimal angiogenic factors. All naive endothelial cells that are non-transduced with E4ORF1 are depleted during passaging in serum-free conditions. Confluent monolayers of E4ECs are contact inhibited, non-transformed and propagate as homogenous monolayers providing an ideal instructive niche for reprogramming and sustaining FGRS-transduced endothelial cells into rEC-hMPPs. Reprogramming of endothelial cells into MPPs (rEC-hMPPs). Endothelial cells were reprogrammed into haematopoietic cells by transduction with transcription factors and vascular niche induction. Purified populations of CD45 2 CD133 2 c-Kit 2 CD31 1 and clonal CD45 2 CD144 1 CD31 1 CD62E 1 full-term HUVECs and adult primary hDMECs were cultured in the endothelial cell growth medium (EM). Then, HUVECs or hDMECs were transduced with lentiviral vectors expressing GFP and a combination of transcription factors-FOSB, GFI1, RUNX1 and SPI1 (FGRS)-and maintained in EM. After 3 days, GFP 1 FGRS transduced endothelial cells were plated in co-culture with 30% to 50% subconfluent E4EC monolayers supplemented with serum-free haematopoietic media (HM) composed of Stem-Span SFEM, 10% KnockOut Serum Replacement, 5 ng ml 21 FGF-2, 10 ng ml 21 EGF, 20 ng ml 21 SCF, 20 ng ml 21 FLT3, 20 ng ml 21 TPO, 20 ng ml 21 IGF-1, 10 ng ml 21 IGF-2, 10 ng ml 21 IL-3, 10 ng ml 21 IL-6. After 3-4 weeks of co-culture the outgrown GFP 1 reprogrammed endothelial cells into human multipotent progenitor cells (rEC-hMPPs) formed typical grape-like haematopoietic colonies. At the end of 4 weeks, human CD45 1 rEC-hMPPs were FACS sorted for: (1) immunophenotypic analyses; (2) methylcellulose-CFC assay (five thousand to ten thousand cells per well); (3) molecular profiling; (4) comparative genomic hybridization; and (5) transplanted retro-orbitally into primary sublethally irradiated (275 rad) 6-weekold NSG mice or sublethally irradiated (100 rad) 2-week-old mice neonates. After 3 months, human CD45 1 cells (hCD45 1 cells) derived from bone marrow or whole bone marrow of the primary engrafted mice were used for transplantation into secondary recipients. After 3 months of primary and 6 months of the secondary transplantation, engrafted hCD45 1 cells in bone marrow, spleen and peripheral blood of mice were FACS sorted and processed for: (1) multivariate immunophenotypic analyses; (2) multi-cell and clonal methylcellulose CFC assay; and (3) molecular profiling. Tissues of the engrafted mice were processed for histological examination to rule out malignant transformation. Increasing efficiency of reprogramming. To increase efficiency of the reprogramming, we developed a strategy to select those subsets of endothelial cells that were most likely transduced with the proper stoichiometry of all four FGRS transcription factors. We initially focused on generating endothelial cells transduced with GFI1, SPI1 and FOSB transcription factors because their expression in endothelial cells is negligible (Extended Data Fig. 1 ). To accomplish this, we transduced 5 3 10 6 endothelial cells with FGRS lentiviral 'cocktail' marked by puromycin resistance (SPI1) or GFP (FOSB and GFI1). We then applied puromycin selection for 2 days to enrich SPI1-expressing cells and sorted them for GFP expression to enrich for SPI1 1 GFP 1 (FOSB/GFI1) endothelial cells. Subsequently, we transduced these GFP 1 puromycin-resistant cells with RUNX1, seeded into 12-well plates, and expanded them for 2 days (10 5 cells per plate, n 5 3). We then re-plated 10 4 of the GFP 1 puromycin-resistant cells on serum-free E4EC vascular niche layer in haematopoietic media and quantified the number of haematopoietic clusters that emerge after ,20 days of co-culture. We found that GFP 1 puromycin-resistant cells yielded 156.0 6 3.6 (n 5 3) haematopoietic-like colonies per 10 4 re-plated cells, suggesting that the efficiency of reprogramming was at least 1.5% (156 of 10 4 ). This calculation assumes that each colony originates from a single reprogrammed cell. The efficiency is probably much higher in cells expressing the appropriate stoichiometric quantities of each factor. Identification of viral integration on a single-cell and single-colony level. To identify the presence of viral integration on a single-cell level, we sorted human CD45 1 cells from the marrow of rEC-hMPP engrafted mice into a 96-well plate (1 cell per well) containing a lysis buffer for the Phi29 (multiple displacement amplification; MDA) based whole-genome amplification (WGA). To do single-cell WGA, we used a commercially available kit, REPLI-g (Qiagen, catalogue no. 150343). Each WGA reaction product was followed by a set of PCR reaction with primers specific to the CMV promoter and a transgene (FOSB, GFI1, RUNX1, SPI1). All PCR reactions were conducted separately. We used empty wells (no cells sorted) as controls for nonspecific amplification. WGA products of the control wells were used for PCR reactions with primers specific to the CMV promoter and a transgene.
To identify the presence of viral integration on a single-cell level, we captured expanding colonies from the plates for CFC assay. Fourteen days after the start of CFC assay 3 distinct cell aggregations/colonies were detected and analysed. Four PCR reactions were performed for each amplified colony using their genomic DNA as template. Cells from the colonies were re-suspended and washed twice in excessive amounts of PBS (10 ml) and transferred into the lysis buffer for the WGA. All following procedures were the same as those described for the single-cell viral integration identification.
CMV primer, 59-CGCAAATGGGCGGTAGGCGTG-39; FOSB primer, 59-GC TCTGCTTTTTCTTCCTCCAACT-39; GFI1 primer, 59-CCAGGGCCCCACAC GGTCGGTAGC-39; RUNX1 primer, 59-TTGCGGTGGGTTTGTGAAGAC-39; SPI1 primer, 59-CGGATCTTCTTCTTGCTGCCTGTC-39. Clonal reprogramming of HUVECs to rEC-hMPPs. HUVECs were isolated from umbilical cord and grown in endothelial cell growth medium. After 2-3 passages, CD144 1 CD31 1 CD62E (E-selectin) 1 CD45 2 HUVECs were FACS sorted into 96-well plates at 1, 2, 5 and 10 cells per well densities for clonal expansion. We used CD62E (E-selectin) surface marker to sort mature activated endothelial cells. Passaging of HUVECs results in upregulation of E-selectin in 40-60% of the HUVECs. Expanding clonal populations of selected cells were subsequently transduced with the FGRS transcription factors followed by re-plating onto the E4EC monolayers to reprogram them into rEC-hMPPs. Haematopoietic activity of clonally derived CD45 1 CD34 1 rEC-hMPPs was assessed using standard methylcellulose-CFC assay. RNA-seq processing and analysis. Total RNA was prepared using the Applied Biosystems Arcturus PicoPure RNA isolation kit. The quality of the extracted RNA was checked on an Agilent Technologies 2100 Bioanalyzer. The extracted RNA was used for sequencing using Illumina HiSeq2000. The sequencing output was checked for quality using Illumina pipeline. PE 51x2 and SE 51 reads were mapped to the human genome (hg18) using TopHat (http://tophat.cbcb.umd.edu/) default parameters. RefSeq transcript levels, identified as fragments per kilobases of transcripts per million of mapped reads (FPKMs), were then quantified using CuffLinks (http://cufflinks.cbcb.umd.edu/) with upper-quartile normalization and sequencespecific bias correction. For heat-map visualization we determined the maximum FPKM of each transcript across the samples shown. FPKMs were then divided by this number to produce scaled expression values. Heat maps of gene expression and gene expression clustering were built using GENE-E matrix visualization and analysis platform (http://www.broadinstitute.org/cancer/software/GENE-E/). Clustering of gene expression in the heat maps was conducted using one minus Pearson correlation as dissimilarity measure between transcription profiles. GEO accession number GSE57662. Comparative genomic hybridization (CGH). Genomic DNA was extracted from HUVECs, FACS sorted CD45 1 rEC-hMPPs and hCD45 1 hCD34 1 rEC-hMPPs sorted from the bone marrow of NSG mice. Before DNA extraction, hCD 45 1 hCD34 1 rEC-hMPPs sorted from the bone marrow were expanded for 72 h in vitro. As a positive control of chromosomal rearrangements we used a CGH array of a leukaemic cell line with a duplication of chromosome 7 and a deletion of chromosome 10. Extracted DNA was digested, labelled by random priming and hybridized to the Agilent 1M CGH arrays. The arrays were scanned in an Agilent DNA microarray scanner and obtained data was visualized using Feature Extraction software (version 10.7; Agilent). Differentiation and reprogramming of human embryonic stem cells (hES). We used a transgenic hES reporter line that specifically identifies differentiated endothelial cell derivatives via a fluorescent reporter driven by a fragment of the human VE-cadherin promoter 1, 35 . To augment endothelial commitment, hES differentiation was initiated in co-culture with E4EC vascular niche cells, described above. One day before plating hES to begin differentiation, MEF conditioned medium was replaced with hES culture medium without FGF-2 and supplemented with 2 ng ml 2l BMP4. The next day, hES cells were plated directly onto E4EC monolayers in hES culture medium (without FGF-2, plus 2 ng ml 2l BMP4) and left undisturbed
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for 48 h. This point of culture was considered as differentiation day zero. Cells were sequentially stimulated with recombinant cytokines in the following order: day 0 to 7, supplemented with 10 ng ml 2l BMP4; day 2 to 14, supplemented with 10 ng ml 2l VEGF-A; day 2 to 14, supplemented with 5 ng ml 2l FGF-2; day 7 to 14, supplemented with 10 mM SB-431542. At day 14 of culture, FACS sorting was used to purify the fraction of hES-derived endothelial cells co-expressing the vascular-specific CD144 (VE-cadherin) reporter and CD31. These cells were transduced with the FGRS cocktail and 2-3 days later plated on a layer of serum-free E4EC monolayers. The extent of reprogramming was assessed by flow cytometry. To accurately detect the expression of CD144 in the hES-ECs being reprogrammed into putative rEC-hMPPs, we used fluorescent monoclonal antibodies to human CD144. Phagocytosis assay. The rEC-hMPPs generated from 3 to 4 weeks were cultured in the presence of M-CSF (10 ng ml 2l ), SCF (10 ng ml 2l ), Flt-3 (10 ng ml 2l ), TPO (10 ng ml 2l ) and 10% FBS for an additional 2 weeks with E4EC vascular niche layer. We observed an increase in size and granularity of the cultured cells (data not shown). The culture was washed with PBS twice to remove non-adherent cells. Growth media mixed with green fluorescent beads (GFB) at a low concentration of 1 ml ml 2l was applied to the attached cells for one hour at 37 uC. After the incubation, the cells were washed twice with PBS and live cells were stained with the monocytic CD14 antibody. Cells were fixed and stained with DAPI for nuclear visualization. We visualized GFB inside CD14 1 cells, but not in CD144 (VE-cadherin) 1 endothelial cells (Extended Data Fig. 2g ). Purification of human cord blood stem and progenitor cells (HSPCs). Human umbilical cord blood was obtained under the IRB protocol 'stage specific differentiation of hematopoietic stem cells into functional hemangiogenic tissue' (Weill Cornell Medical College IRB 09060010445). Cord blood mononuclear cells were purified by density gradient using Ficoll-Paque (GE) and enriched for CD34 1 HSPCs using magnetic separation using anti-CD34 microbeads (Miltenyi) or FACS sorting. Further purification was achieved by negative selection of Lin 1 cells using the human progenitor cell enrichment kit (StemCell Technologies) or FACS sorting. RNA from FACS sorted Lin 2 CD34 1 CD45 1 cells was isolated by using Arcturus PicoPure RNA isolation kit (Applied Biosystems; this kit was used for all RNA extraction procedures). Lentiviral vectors. Candidate transcription factors used for screening were subcloned into pLVX-IRES-ZsGreen1 lentivector (Clontech), pLOC lentivector (Open-Biosystems), or LV105 and LV151 lentivectors (Genecopoeia). pLOC lentiviral vector contained CMV-MCS-IRES-GFP (MCS, multicloning site where a cDNA of interest such as FOSB or GFI1 was subcloned). Human FGRS were subcloned as follows: FOSB and GFI1 were each subcloned into pLOC lentivector containing IRES-GFP cassette, SPI1 was subcloned into LV105 lentivector containing puromycin selection marker, and RUNX1 was subcloned into LV151 lentivector containing neomycin selection marker. Tet-On 3G inducible lentivectors (Clontech) were used for inducible expression of either mouse FGRS (mFGRS) or human FGRS (hFGRS) factors. Expression of all FGRS transgenes was driven by the CMV promoter. Lentiviral particles were packaged as previously described 7 . In short, human embryonic kidney 293FT (HEK293FT) cells were co-transfected with a lentiviral vector and two helper plasmids, psPAX2 and pMD2.G (Trono Lab through Addgene), in an equal molar ratio. Supernatant was collected 48-52 h after transfection, filtered and concentrated using Lenti-X concentrator (Clontech). Viral titres were determined in limiting dilution experiments using HUVECs as target cells. We used either the number of GFP 1 cells or the number of formed colonies in the presence of selection antibiotics (puromycin) as a read-out for the number of infectious viral particles per volume. We used an average multiplicity of infection (MOI) of 5 to 10 for infection of endothelial cells. Flow cytometry. Flow cytometry analysis was performed on a Becton Dickenson LSRII SORP, and FACS was performed on an Aria II SORP. Antibodies used were raised against human CD45, CD34, CD14, CD31, CD43, CD90, CD41a, CD33, CD19, CD3, CD4, CD8, CD235, CD45RA, CD83, CD11b, CD38, Lin cocktail, CD117, CD133, CD144 (BD Pharmingen, eBioscience) or mouse CD45 (eBioscience.) Voltage adjustments and compensation was performed with CompBeads (BD Pharmingen), and gating was performed on fluorophore minus one (FMO) controls and unstained controls.
The list of antibodies used in our experiments is given below. Anti-human antibodies obtained from EBioscience: CD45 catalogue no. 47-0459-42; clone HI30, CD34 catalogue no. 25-0349-42; clone 4H11, CD33 catalogue no. 48-0337-42; clone p67.6, CD19 catalogue no. 12-0199-41; clone HIB19, CD3 catalogue no. 93-0037-42; clone OKT3, CD4 catalogue no. 17-0048-41; clone OKT4, CD8 catalogue no. 8048-0087-025; clone SK1, CD43 catalogue no. 17-0439-73; clone eBio84-3C1, CD83 catalogue no. 25-0839-41; clone HB15e, CD11b catalogue no. 12-0118-41; clone ICRF44, LIN catalogue no. 22-7778-72, CD31 catalogue no. 11-0319-42; clone WM59, CD31 catalogue no. 48-0319-42; clone WM59. Anti-human antibodies obtained from BD Pharmingen: CD90 catalogue no. 561971; clone 5E10, CD3 catalogue no. 557851; clone SK7, CD14 catalogue no. 557742, CD14 catalogue no. 555399, CD235A catalogue no. 340947, CD45RA catalogue no. 347723, CD41a catalogue no. 555466, CD38 catalogue no. 646851, CD117 catalogue no. 333944, CD33 catalogue no. 333946, CD144 catalogue no. 560410; clone 55-7H1, FLK1(VEGF-R2) catalogue no. 560871; clone 89106. Anti-human antibodies obtained from BioLegend: Lin catalogue no. 348805. Anti-mouse antibodies obtained from Ebioscience: CD45 catalogue no. 25-0451-82; clone 30-f11. Statistics and animals. All statistics are presented as average 6 standard deviation. To identify statistical significance all groups of data were compared using a paired student t-test. Experiments were repeated for at least three times. Number of repeats is demonstrated in all figure legends. Animal experiments contain at least three animals per group. The number of animals is described in all figure legends and the text of the paper. We included all tested animals for quantification. Representative images and flow cytometry plots are shown in the figures. Age-and sexmatched animals were allocated in all corresponding experimental groups. All NSG (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ, Jackson laboratory) animals for transplantation experiments were female. All ages are specified in the text. Animals were chosen according to their age and their sex (females only). A description of every experiment states the age of the animals used in the experiment. Transplanted animals were not individually labelled. Hence, subgroups of transplanted animals for organ engraftment were chosen blindly, without previous knowledge of the level of engraftment. Animal experiments were performed under the guidelines set by the Institutional Animal Care and Use Committee (IACUC).
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Extended Data Figure 5 | Single-cell analysis of lentiviral integration into engrafted rEC-hMPPs. Engrafted hCD45 1 rEC-hMPPs purified from the bone marrow of primary NSG recipient mouse (Fig. 3e, f) were sorted into a 96-well plate (1 cell per well), lysed in corresponding well for whole genome amplification (WGA) using Phi29 enzyme (see Methods). Amplified DNA is shown for all 21 cells in the top two gels. Amplified DNA was used as a template for PCR reactions with a forward primer specific for the CMV promoter and reverse primer specific for the coding sequence of a reprogramming factor. t-test PCR with a lentiviral vector. EW indicates empty well (no template DNA). Red asterisks show failed PCR amplification of viral integration. PCR products are visible as low molecular mass bands labelled as 1, FOSB; 2, GFI1; 3, RUNX1; 4, SPI1.
